个股
共 6,269 份研报 · 国内 4,013 · 国外 1,837
海通国际-数据港(603881.SH):业绩短期承压,关注AIDC增量
海通国际·2026-11-06·11 页·A股
Morgan Stanley & Co. LLC-BeOne Medicines(ONC.O):BeOne Medicines(ONC.O):2026年三季报:实体瘤迎来拐点,ASH 年会聚焦血液肿瘤
BeOne Medicines (ONC.O): 3Q26 Results: Solid-Tumor Inflection, Heme-Heavy ASH
Morgan Stanley & Co. LLC·2026-11-06·23 页·美股
华安证券-龙佰集团(002601.SZ):硫酸成本回落,布局西澳钛锆矿砂保障原料供应
华安证券·2026-11-06·4 页·其它
Nomura International (Hong Kong) Ltd.-药明康德(2359.HK):2026年投资者日纪要
Wuxi Apptec (2359.HK): 2026 Investor Day takeaway
Nomura International (Hong Kong) Ltd.·2026-11-06·6 页·港股
Nomura-泸州老窖(000568.SZ):盈利承压,核心产品价格稳定
Earnings pressured; core-product pricing stable
Nomura·2026-11-06·11 页·A股
J.P. Morgan-南亚塑料(1303.TW):电子材料景气延续至四季度,ASIC 项目参与度指引上行,重申增持
Nan Ya Plastics Corp (1303.TW): Electronic materials beat extends into 4Q; guiding rising ASIC project exposure. Re-iterate OW
J.P. Morgan·2026-11-06·12 页·个股
J.P. Morgan-康明斯(CMI.US):康明斯(CMI):下调盈利预测与目标价
Cummins Inc (CMI): Lowering Estimates & PT
J.P. Morgan·2026-11-06·17 页·美股
J.P. Morgan-Light & Wonder Inc (AU)(LNW AU):摩根大通-澳大利亚率先抢占市场-261106
Light & Wonder Inc (AU) (LNW AU): Back to the Future … again: downgrade to Neutral
J.P. Morgan·2026-11-06·13 页·个股
JPMorgan Securities Japan Co., Ltd.-Niterra(5334.T):Niterra(5334.T):二季度业绩说明会报告——中长期前景稳固
Niterra (5334): 2Q results briefing report: Medium-term outlook solid
JPMorgan Securities Japan Co., Ltd.·2026-11-06·10 页·个股
J.P. Morgan-HelloFresh(HFGG.DE):HelloFresh(HFGG.DE):四季度聚焦利润率修复,1月将成下一增长考验
HelloFresh (HFGG.DE): Margin recovery in focus for Q4 with January as the next growth test
J.P. Morgan·2026-11-06·12 页·个股
J.P. Morgan-Bharti Hexacom(BHAX.NS):Bharti Hexacom(BHAX.NS)首次解读:业绩大致符合预期,无线用户新增放缓
Bharti Hexacom: First Take: Broadly in-line results; softer wireless sub adds
J.P. Morgan·2026-11-06·9 页·个股
Goldman Sachs-再鼎医药(ZLAB.US):再鼎医药 (ZLAB):三季度销售符合预期;zoci关键性试验成为2027年关注焦点
Zai Lab (ZLAB): 3Q sales inline; Zoci pivotal trials in focus towards 2027
Goldman Sachs·2026-11-06·8 页·美股
高盛-华虹半导体(1347.HK):2026年四季度指引与2026年三季度业绩均超预期,华力微并表后需求强劲;维持买入评级
Hua Hong (1347.HK): 4Q26 guidance and 3Q26 results beat; Strong demand with Huali in scope of consolidation; Buy
高盛·2026-11-06·9 页·港股
Goldman Sachs-鸿海(2317.TW):10月营收符合预期,同比增长46%;AI服务器新机架、CPO交换机与折叠手机将驱动第四季度增长;评级买入(列入确信名单)
Hon Hai (2317.TW): Oct in line: revenues +46% YoY; New AI servers, CPO switch and Foldable phones to drive 4Q26; Buy (on CL)
Goldman Sachs·2026-11-06·9 页·个股
高盛-Unity Software(U.N):2026年第三季度业绩回顾:Vector业务表现超预期推动业绩超预期并上调指引,长期战略逐步成为焦点
Q3'26 Earnings Review: Vector Outperformance Drives Beat & Raise; Longer Term Strategy Coming Into Focus
高盛·2026-11-06·10 页·美股
Goldman Sachs-IREN Ltd.(IREN):IREN有限公司(IREN)2027财年一季度回顾:EBITDA超预期、定价趋势有利、资本开支更具灵活性
IREN Ltd. (IREN) F1Q27 Review: EBITDA beat, favorable pricing trends, and capex flexibility
Goldman Sachs·2026-11-06·9 页·个股
Morgan Stanley-Seagate Technology(STX.US):希捷科技(STX.US):管理层会议凸显强劲基本面与疲弱市场情绪之间的脱节
Seagate Technology (STX): Management Meetings Highlight the Disconnect Between Strong Fundamentals and Weak Sentiment
Morgan Stanley·2026-11-06·24 页·美股
Cybertruck 让位于 Cybercab
Cybertruck Yields to Cybercab
Morgan Stanley·2026-11-06·8 页·美股
摩根士丹利-礼来(LLY.N):礼来(LLY.N):Mounjaro、Zepbound与Foundayo处方药追踪
Eli Lilly & Co. (LLY.N): Mounjaro+Zepbound+Foundayo Script Tracker
摩根士丹利·2026-11-06·37 页·美股
Morgan Stanley-BeOne Medicines(ONC.O):百济神州(ONC.O):2026年三季报:实体瘤业务拐点显现,血液瘤ASH数据密集
BeOne Medicines (ONC.O): 3Q26 Results: Solid-Tumor Inflection, Heme-Heavy ASH
Morgan Stanley·2026-11-06·23 页·美股
显示 2281 - 2300 条,共 6,269 条